[18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy.
De Giorgi
Ugo
U
Amadori
Dino
D
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D018450:Disease Progression; D018572:Disease-Free Survival; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism*; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000378:metabolism; D049268:Positron-Emission Tomography; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism*; D019275:Radiopharmaceuticals; D020123:Sirolimus / Q000627:therapeutic use*; D058570:TOR Serine-Threonine Kinases; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D005462:Fluorine Radioisotopes; D047908:Intracellular Signaling Peptides and Proteins; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C546842:MTOR protein, human; D017346:Protein Serine-Threonine Kinases; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus